{"id":4473,"date":"2021-12-17T07:03:47","date_gmt":"2021-12-17T07:03:47","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=podcasts_and_videos&p=4473"},"modified":"2023-03-22T11:59:22","modified_gmt":"2023-03-22T16:59:22","slug":"covid-19-implications-for-pharmaceutical-litigation","status":"publish","type":"podcasts_and_videos","link":"https:\/\/www.cornerstone.com\/insights\/podcasts\/covid-19-implications-for-pharmaceutical-litigation\/","title":{"rendered":"COVID-19 Implications for Pharmaceutical Litigation"},"content":{"rendered":"","protected":false},"featured_media":3602,"template":"","categories":[65],"tags":[],"asset_type":[28],"class_list":["post-4473","podcasts_and_videos","type-podcasts_and_videos","status-publish","has-post-thumbnail","hentry","category-life-sciences"],"acf":[],"yoast_head":"\n